Editor's corner: Fierce Pharma's top 10 stories of 2022
Fierce Pharma
DECEMBER 21, 2022
Editor's corner: Fierce Pharma's top 10 stories of 2022. Wed, 12/21/2022 - 08:42. esagonowsky.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Fierce Pharma
DECEMBER 21, 2022
Editor's corner: Fierce Pharma's top 10 stories of 2022. Wed, 12/21/2022 - 08:42. esagonowsky.
Fierce Pharma
DECEMBER 15, 2022
Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access. Thu, 12/15/2022 - 10:51.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
NOVEMBER 10, 2022
How pharma marketing must adapt to patient personalization. Thu, 11/10/2022 - 18:32.
Fierce Pharma
DECEMBER 18, 2022
2023 forecast: FDA revamps cancer drug approvals, and Big Pharma is willing to fall in line. Sun, 12/18/2022 - 17:18.
Fierce Pharma
DECEMBER 12, 2022
In another leadership change at Roche, Anderson departs as pharma CEO. Mon, 12/12/2022 - 09:25.
Fierce Pharma
DECEMBER 20, 2022
Thea Pharma gets FDA nod for preservative-free rival to Sun and Viatris glaucoma eye drops. Tue, 12/20/2022 - 04:53.
Fierce Pharma
DECEMBER 6, 2022
Leo Pharma scores with its JAK inhibitor cream in chronic hand eczema trial. Tue, 12/06/2022 - 10:04.
World of DTC Marketing
JANUARY 1, 2022
3hree: Pharma will increase its spending in digital, but a lot of the money will be wasted. Studies show that tens of millions of dollars are being wasted due to fraud with programmatic advertising, but many pharma companies are still wasting money on the channel. The post A realistic view of healthcare in 2022.
Fierce Pharma
DECEMBER 2, 2022
Fierce Pharma Asia—Eisai's lecanemab Alzheimer's debate; BeiGene's Imbruvica showdown; Shionogi's COVID drug nod. Fri, 12/02/2022 - 08:55.
Fierce Pharma
NOVEMBER 18, 2022
Fierce Pharma Asia—BioNTech, GSK grow in Singapore; Astellas' stomach cancer win; Daiichi's mRNA vaccine readout. Fri, 11/18/2022 - 09:44.
Fierce Pharma
NOVEMBER 10, 2022
Divya Iyer, VP Strategy & Business Development at GoodRx, showcases digital health innovations at Digital Pharma East conference. Thu, 11/10/2022 - 13:14.
Fierce Pharma
JANUARY 17, 2024
GSK is sticking to its plan to gradually monetize its stake in Haleon, the consumer health business the British pharma giant spun off in 2022. | GSK is sticking to its plan to gradually monetize its stake in Haleon, the consumer health business the British pharma giant spun off in 2022.
Fierce Pharma
APRIL 7, 2023
After 2022's M&A spree, Amgen CEO Bradway collects $21.4M payday zbecker Fri, 04/07/2023 - 12:10
Fierce Pharma
MARCH 7, 2023
AbbVie CEO Gonzalez scored $26M in 2022 pay as cash cow Humira neared patent cliff aliu Tue, 03/07/2023 - 10:54
Fierce Pharma
MARCH 20, 2023
in 2022 pay as stock price hit all-time high aliu Mon, 03/20/2023 - 10:51 Eli Lilly CEO racked up $21.4M
Fierce Pharma
MARCH 7, 2024
After posting revenue increases for six straight years, including double-digit growth in 2021 and 2022, Merck KGaA took a hard fall last year, with its global sales
Fierce Pharma
NOVEMBER 29, 2022
Amgen, J&J and Sanofi size up Horizon as Big Pharma renews interest in rare disease M&A. Wed, 11/30/2022 - 00:16.
Fierce Pharma
JULY 27, 2023
To Roche’s pharma chief Teresa Graham, no word better describes the company’s eye drug Vabysmo right now than “momentum.” | To Roche’s pharma chief Teresa Graham, no word better describes the company’s eye drug Vabysmo right now than “momentum.”
Fierce Pharma
JUNE 26, 2023
There was a decline in CEO compensation overall in 2022. But there was no evidence of the slide in biopharma where pay increases were plentiful.
World of DTC Marketing
MARCH 8, 2022
It’s hard to justify those price increases, but pharma is big business, as all parties in healthcare are. Many people I talk with acknowledge that pharma has been profiteering from drug sales, but they balance that with the need for new drugs to help patients live a better quality of life. million people have died.
Fierce Pharma
APRIL 5, 2024
million pay in 2022. Vertex CEO Reshma Kewalramani, M.D., million in 2023, which was an increase of 30% from her $15.9
Fierce Pharma
NOVEMBER 10, 2022
Thu, 11/10/2022 - 09:02. AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments.
World of DTC Marketing
FEBRUARY 19, 2021
When will pharma stop using programmatic online ads? Again and again, I have seen robust fraud and online ads being placed on sites that pharma would normally block in their system. If pharma is going to waste money like this perhaps they could send the money to those who need it. dollars in 2018.
Fierce Pharma
MARCH 15, 2024
After a difficult year for Pfizer, in which its share price fell by 44%, CEO Albert Bourla’s compensation fell by 35% from $33 million in 2022 to $21.6 But even the drugmaker was surprised by the plummeting demand for its COVID-19 products, missing badly on its 2023 guidance. million in 2023.
Fierce Pharma
DECEMBER 15, 2023
About a year after Arcutis Biotherapeutics unveiled positive data on roflumilast foam at the European Academy of Dermatology and Venereology congress 2022, the company has clinched a second FDA OK.
Fierce Pharma
DECEMBER 22, 2022
Thu, 12/22/2022 - 12:38. Pfizer, Sanofi settle first California Zantac case slated for trial: report.
Fierce Pharma
AUGUST 8, 2024
million to “partly replenish” Jynneos vaccine stocks in response to the 2022 outbreak of mpox, the disease formerly known as monkeypox. . | The Biomedical Advanced Research and Development Authority (BARDA) is handing Bavarian Nordic $156.8
Fierce Pharma
JANUARY 26, 2024
In late 2022, GSK, Sanofi and Takeda signed on with a partnership of local agencies to advance biologic manufacturing in Singapore. | In late 2022, GSK, Sanofi and Takeda signed on with a partnership of local agencies to advance biologic manufacturing in Singapore.
Fierce Pharma
JULY 8, 2024
Since Roche gained approval for its eye disease medication Vabysmo in 2022, it has stormed a market dominated by Regeneron and Bayer’s Eylea. Since Roche gained approval for its eye disease medication Vabysmo in 2022, it has stormed a market dominated by Regeneron and Bayer’s Eylea.
Fierce Pharma
DECEMBER 13, 2022
Tue, 12/13/2022 - 20:12. Cancer center leaders lay bare CAR-T makers' struggles—and an unexpected laggard.
Fierce Pharma
DECEMBER 29, 2022
Thu, 12/29/2022 - 14:42. Biogen, FDA's inappropriate Aduhelm coordination detailed in blistering congressional report. aarmstrong.
Fierce Pharma
DECEMBER 9, 2022
Fri, 12/09/2022 - 09:15. ASH: Bristol Myers bolsters Breyanzi's case in earlier lymphoma amid clash with Gilead.
Fierce Pharma
NOVEMBER 8, 2022
Tue, 11/08/2022 - 11:03. Moderna’s Spikevax carries higher risk of myocarditis than Pfizer's Comirnaty, study says.
Fierce Pharma
DECEMBER 19, 2022
Mon, 12/19/2022 - 14:06. Atara makes history with world-first nod for allogeneic T-cell therapy Ebvallo. fkansteiner.
Fierce Pharma
NOVEMBER 7, 2022
Mon, 11/07/2022 - 09:45. GSK's CAR-T rival Blenrep fails multiple myeloma trial, endangering its accelerated approval.
Fierce Pharma
DECEMBER 15, 2022
Fierce Pharma Asia—Gracell's CAR-T wows, Takeda puts down $4B on Nimbus' TYK2 inhibitor, Bio Farma strikes Merck deal. Thu, 12/15/2022 - 20:11.
Fierce Pharma
DECEMBER 12, 2022
Mon, 12/12/2022 - 14:25. ASH: CSL, uniQure's gene therapy Hemgenix shows durable protection in hemophilia B.
Fierce Pharma
AUGUST 15, 2024
Just as a new strain of mpox spreads across Africa, results from a preliminary analysis of a study that began during the 2022 viral outbreak stands to provide more clarity on the clinical benefit o | Despite missing the trial's primary endpoint of time to lesion resolution, the study suggested that the treatment may be most beneficial for those (..)
Fierce Pharma
NOVEMBER 16, 2022
Wed, 11/16/2022 - 09:44. NICE gives thumbs-down to 5 COVID-19 drugs including AZ's Evusheld and Merck's Lagevrio.
Fierce Pharma
DECEMBER 2, 2022
Fri, 12/02/2022 - 09:51. With buyout on Horizon, Amgen and Sanofi eye cash plays for rare disease drug maker. fkansteiner.
Fierce Pharma
NOVEMBER 23, 2022
Wed, 11/23/2022 - 10:10. Sporting a $3.5M price tag, CSL and uniQure's hemophilia B gene therapy crosses FDA finish line.
Fierce Pharma
NOVEMBER 17, 2022
Thu, 11/17/2022 - 13:27. Nothing to sneeze at: AstraZeneca donates thousands of nasal spray flu vaccines after Swiss pricing row. fkansteiner.
Fierce Pharma
FEBRUARY 1, 2024
billion in 2022 and $55.1 With Merck reporting a whopping $25 billion sales haul for | With Merck reporting a whopping $25 billion sales haul for Keytruda on Thursday, the PD-1 cancer superstar appears to be the world’s top-selling drug in 2023. billion in 2021.
Fierce Pharma
DECEMBER 14, 2022
Wed, 12/14/2022 - 09:00. Senators blast Pfizer's proposed COVID vaccine price hike as 'profiteering'. fkansteiner.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content